RT Journal Article
SR Electronic
T1 Occupational lead exposure in gasoline station forecourt attendants and other occupations in relation to ALS (amyotrophic lateral sclerosis) risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.27.23290632
DO 10.1101/2023.05.27.23290632
A1 Koski, Lassi
A1 Tshoni, Unathi A.
A1 Olowoyo, Joshua O.
A1 Kobyana, Aprilia S.
A1 Lion, Ntebo G.
A1 Mugivhisa, Liziwe L.
A1 Wärmländer, Sebastian K.T.S.
A1 Roos, Per M.
YR 2023
UL http://medrxiv.org/content/early/2023/06/01/2023.05.27.23290632.abstract
AB Amyotrophic lateral sclerosis (ALS) is an always fatal neurodegenerative disease characterised by a gradual death of motor neurons in the spinal cord and brain. The cause of ALS is unknown. There appears to be both a genetic and an environmental aspect of ALS disease causation. Multiple occupations are associated with an elevated ALS risk. Interestingly, many of these occupations involve exposure to lead, indicating a possible connection between ALS and lead exposure. Examples include mechanical workers, military service occupations, leather workers and tanners. Gasoline station forecourt attendants, also known as petrol station assistants, show a severely increased ALS risk, and our measurements on forecourt attendants in South Africa show that they display significantly elevated blood lead concentrations. Thus, forecourt attendants can be added to the list of occupations with overlapping risks for lead exposure and ALS incidence. These occupational risks for forecourt attendants are expected to decrease in the future, as leaded gasoline is being phased out worldwide. Nonetheless, the overlapping risks for ALS incidence and lead exposure among forecourt attendants and several other occupations strengthen the hypothesis that lead exposure contributes to ALS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupport to SW from the Magnus Bergvall foundation and support to PMR from the Kamprad Research Foundation, the Magnus Bergvall Research Foundation, the Ulla-Carin Lindquist Foundation for ALS Research and the Karolinska Institutet IMM strategic grants is gratefully acknowledged. The support from NRF, South Africa is also greatly appreciated.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the project was provided by the Sefako Makgatho Health Sciences Research Committee (SMUREC/S/91/2020:PG)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.